Login / Signup

Case Report And Review Of The Literature: Immune Dysregulation In A Large Familial Cohort Due To A Novel Pathogenic RELA Variant.

Kelsey LecerfDaniel C KoboldtHye Sun KuehnVijayakumar JayaramanKristy LeeTheresa Mihalic MosherJennifer R YonkofMari MoriScott E HickeySamuel FranklinJoanne DrewShoghik AkoghlanianVidya SivaramanSergio D RosenzweigRichard K WilsonRoshini S Abraham
Published in: Rheumatology (Oxford, England) (2022)
Family members with this novel RELA variant have a clinical phenotype similar to other reported RELA cases with predominant chronic mucocutaneous ulceration; however, the clinical phenotype broadens to include Behçet's syndrome and inflammatory bowel disease (IBD). Here we describe the clinical, immunological, and genetic evaluation of a large kindred to further expand identification of patients with autosomal dominant RELA deficiency, facilitating earlier diagnosis and intervention. The functional impairment of the canonical NFκB pathway suggests that this variant is causal for the clinical phenotype in these patients.
Keyphrases
  • randomized controlled trial
  • end stage renal disease
  • ejection fraction
  • gene expression
  • prognostic factors
  • early onset
  • inflammatory response
  • toll like receptor
  • ulcerative colitis
  • lps induced
  • nuclear factor